Shop

Retatrutide is an investigational peptide that acts as a triple agonist of the GLP-1, GIP, and glucagon receptors. This multi-receptor design has positioned Retatrutide as a unique molecule within metabolic research, as it engages three distinct hormonal pathways involved in energy regulation.

GLP-1 and GIP receptor activation are associated with incretin signaling related to insulin secretion, satiety, and nutrient metabolism. The addition of glucagon receptor activity introduces a separate metabolic pathway involved in energy expenditure and lipid metabolism. Researchers are studying how the combined activation of these systems may influence overall metabolic efficiency and energy utilization.

Scientific investigations into Retatrutide have explored its potential roles in appetite signaling, metabolic flexibility, adipose-tissue regulation, and glucose homeostasis. Studies are also examining its influence on liver metabolism, lipid pathways, and energy-expenditure mechanisms.

Due to its triple-agonist activity across three key metabolic receptors, Retatrutide represents a novel area of exploration within endocrine and metabolic science.